MedTrace Logo

An Observational Retrospective Database Analysis to Evaluate Raltegravir Based-regimens, Including NUC-sparing Regimens, in Aged HIV Patients.(RalAge)

NCT03579485 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2023-02-08

No results posted yet for this study

Summary

This is an observational retrospective cohort in real world to describe RAL data, including NUC-sparing regimens, in aged HIV patients. It is a phase IV study.

90 patients will be enrolled from the Department of Public Health and Infectious Diseases of "Sapienza" University of Rome.

In this retrospective analysis all naïve patients on raltegravir-based regimens and all patients switched to raltegravir-based regimens will be considered.

Conditions

Sponsors & Collaborators

  • Azienda Policlinico Umberto I

    lead OTHER

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-31
Primary Completion
2023-12-31
Completion
2024-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03579485 on ClinicalTrials.gov